Zum Hauptinhalt springen
Hochschulbibliothek Niederrhein

Suchergebnisse

Katalog

Mehr
216 Treffer

Suchmaske

Suchtipp für den Bereich Mehr: Wörter werden automatisch mit UND verknüpft. Eine ODER-Verknüpfung erreicht man mit dem Zeichen "|", eine NICHT-Verknüpfung mit einem "-" (Minus) vor einem Wort. Anführungszeichen ermöglichen eine Phrasensuche.
Beispiele: (burg | schloss) -mittelalter, "berufliche bildung"

Suchergebnisse einschränken oder erweitern

Aktive Suchfilter

Erscheinungszeitraum

Mehr Treffer

Weniger Treffer

Art der Quelle

Thema

Verlag

Sprache

Geographischer Bezug

Inhaltsanbieter

216 Treffer

Sortierung: 
  1. Detailansicht für Treffer 1 öffnen
    A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Fimasartan/Amlodipine Combined Therapy Versus Fimasartan Monotherapy in Patients With Essential Hypertension Unresponsive to Fimasartan Monotherapy.
    Kim, KI ; Shin, MS ; et al.
    In: Clinical therapeutics, Jg. 38 (2016-10-01), Heft 10, S. 2159-2170
    academicJournal
    Wie komme ich dran?
  2. Detailansicht für Treffer 2 öffnen
    A Randomized, Double-blind, Candesartan-controlled, Parallel Group Comparison Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Patients with Mild to Moderate Essential Hypertension.
    Lee, JH ; Yang, DH ; et al.
    In: Clinical therapeutics, Jg. 38 (2016-06-01), Heft 6, S. 1485-1497
    academicJournal
    Wie komme ich dran?
  3. Detailansicht für Treffer 3 öffnen
    A Randomized, Multicenter, Double-blind, Placebo-controlled, 3 × 3 Factorial Design, Phase II Study to Evaluate the Efficacy and Safety of the Combination of Fimasartan/Amlodipine in Patients With Essential Hypertension.
    Lee, HY ; Kim, YJ ; et al.
    In: Clinical therapeutics, Jg. 37 (2015-11-01), Heft 11, S. 2581-2596.e3
    academicJournal
    Wie komme ich dran?
  4. Detailansicht für Treffer 4 öffnen
    Evaluation of the Efficacy and Safety of the Lercanidipine/Valsartan Combination in Korean Patients With Essential Hypertension Not Adequately Controlled With Lercanidipine Monotherapy: A Randomized, Multicenter, Parallel Design, Phase III Clinical Trial.
    Na, SH ; Lee, HY ; et al.
    In: Clinical therapeutics, Jg. 37 (2015-08-01), Heft 8, S. 1726-39
    academicJournal
    Wie komme ich dran?
  5. Detailansicht für Treffer 5 öffnen
    Evaluation of the efficacy and tolerability of fixed-dose combination therapy of azilsartan and amlodipine besylate in Japanese patients with grade I to II essential hypertension.
    Rakugi, H ; Nakata, E ; et al.
    In: Clinical therapeutics, Jg. 36 (2014-05-01), Heft 5, S. 711-21
    academicJournal
    Wie komme ich dran?
  6. Detailansicht für Treffer 6 öffnen
    Ambulatory blood pressure response to once-daily fimasartan: an 8-week, multicenter, randomized, double-blind, active-comparator, parallel-group study in Korean patients with mild to moderate essential hypertension.
    Lee, H ; Kim, KS ; et al.
    In: Clinical therapeutics, Jg. 35 (2013-09-01), Heft 9, S. 1337-49
    academicJournal
    Wie komme ich dran?
  7. Detailansicht für Treffer 7 öffnen
    Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Rakugi, H ; Ogihara, T ; et al.
    In: Clinical therapeutics, Jg. 34 (2012-04-01), Heft 4, S. 838-48
    academicJournal
    Wie komme ich dran?
  8. Detailansicht für Treffer 8 öffnen
    Effectiveness of barnidipine 10 or 20 mg plus losartan 50-mg combination versus losartan 100-mg monotherapy in patients with essential hypertension not controlled by losartan 50-mg monotherapy: A 12-week, multicenter, randomized, open-label, parallel-group study.
    Parati, G ; Giglio, A ; et al.
    In: Clinical therapeutics, Jg. 32 (2010-07-01), Heft 7, S. 1270-84
    academicJournal
    Wie komme ich dran?
  9. Detailansicht für Treffer 9 öffnen
    Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada, K ; Ogihara, T ; et al.
    In: Clinical therapeutics, Jg. 32 (2010-05-01), Heft 5, S. 861-81
    academicJournal
    Wie komme ich dran?
  10. Detailansicht für Treffer 10 öffnen
    Evaluation of the dose--response relationship of aliskiren, a direct renin inhibitor, in an 8-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled study in adult patients with stage 1 or 2 essential hypertension.
    Puig, JG ; Schunkert, H ; et al.
    In: Clinical therapeutics, Jg. 31 (2009-12-01), Heft 12, S. 2839-50
    academicJournal
    Wie komme ich dran?
  11. Detailansicht für Treffer 11 öffnen
    Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino, FW
    In: Clinical therapeutics, Jg. 31 (2009-09-01), Heft 9, S. 1946-56
    academicJournal
    Wie komme ich dran?
  12. Detailansicht für Treffer 12 öffnen
    Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial.
    Kim, SH ; Chung, WY ; et al.
    In: Clinical therapeutics, Jg. 31 (2009-05-01), Heft 5, S. 988-98
    academicJournal
    Wie komme ich dran?
  13. Detailansicht für Treffer 13 öffnen
    Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp, T ; Smith, TR ; et al.
    In: Clinical therapeutics, Jg. 29 (2007-04-01), Heft 4, S. 563-80
    academicJournal
    Wie komme ich dran?
  14. Detailansicht für Treffer 14 öffnen
    Effect on the development of ankle edema of adding delapril to manidipine in patients with mild to moderate essential hypertension: a three-way crossover study.
    Fogari, R ; Malamani, G ; et al.
    In: Clinical therapeutics, Jg. 29 (2007-03-01), Heft 3, S. 413-8
    academicJournal
    Wie komme ich dran?
  15. Detailansicht für Treffer 15 öffnen
    A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).
    Palma Gámiz, JL ; Pêgo, M ; et al.
    In: Clinical therapeutics, Jg. 28 (2006-12-01), Heft 12, S. 2040-51
    academicJournal
    Wie komme ich dran?
  16. Detailansicht für Treffer 16 öffnen
    The effect of losartan and amlodipine on serum adiponectin in Japanese adults with essential hypertension.
    Watanabe, S ; Okura, T ; et al.
    In: Clinical therapeutics, Jg. 28 (2006-10-01), Heft 10, S. 1677-85
    academicJournal
    Wie komme ich dran?
  17. Detailansicht für Treffer 17 öffnen
    Association between human atrial natriuretic peptide Val7Met polymorphism and baseline blood pressure, plasma trough irbesartan concentrations, and the antihypertensive efficacy of irbesartan in rural Chinese patients with essential hypertension.
    Zhang, S ; Mao, G ; et al.
    In: Clinical therapeutics, Jg. 27 (2005-11-01), Heft 11, S. 1774-84
    academicJournal
    Wie komme ich dran?
  18. Detailansicht für Treffer 18 öffnen
    Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière, Y ; Neutel, JM ; et al.
    In: Clinical therapeutics, Jg. 27 (2005-11-01), Heft 11, S. 1795-805
    academicJournal
    Wie komme ich dran?
  19. Detailansicht für Treffer 19 öffnen
    Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
    Mugellini, A ; Dobovisek, J ; et al.
    In: Clinical therapeutics, Jg. 26 (2004-09-01), Heft 9, S. 1419-26
    academicJournal
    Wie komme ich dran?
  20. Detailansicht für Treffer 20 öffnen
    Once-daily fixed-combination irbesartan 300 mg/ hydrochlorothiazide 25 mg and circadian blood pressure profile in patients with essential hypertension.
    Coca, A ; Calvo, C ; et al.
    In: Clinical therapeutics, Jg. 25 (2003-11-01), Heft 11, S. 2849-64
    academicJournal
    Wie komme ich dran?
xs 0 - 576
sm 576 - 768
md 768 - 992
lg 992 - 1200
xl 1200 - 1366
xxl 1366 -